Hims & Hers

Hims & Hers, founded in 2017, is a leading telehealth and wellness platform operating in the United States. The company connects consumers with licensed healthcare providers for personalized care, offering prescription and over-the-counter medications, comprehensive lab testing, and ongoing support. Its virtual platform aims to make treatment more accessible, particularly for sensitive health conversations.

The company is publicly traded on the New York Stock Exchange under the ticker symbol HIMS. It has been recognized as one of the fastest-growing direct-to-consumer brands in history, serving millions of consumers. Hims & Hers has secured over $200 million in funding to support its growth and expansion.